These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8059917)

  • 1. Characterization of naturally acquired human IgG responses against the N-terminal region of the merozoite surface protein 1 of Plasmodium vivax.
    Levitus G; Mertens F; Speranca MA; Camargo LM; Ferreira MU; del Portillo HA
    Am J Trop Med Hyg; 1994 Jul; 51(1):68-76. PubMed ID: 8059917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil.
    Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA
    Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human IgG responses against the N-terminal region of the Merozoite Surface Protein 1 of Plasmodium vivax.
    del Portillo HA; Levitus G; Camargo LM; Ferreira MU; Mertens F
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():77-84. PubMed ID: 1343729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria.
    Soares IS; Levitus G; Souza JM; Del Portillo HA; Rodrigues MM
    Infect Immun; 1997 May; 65(5):1606-14. PubMed ID: 9125537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.
    Lima-Junior JC; Jiang J; Rodrigues-da-Silva RN; Banic DM; Tran TM; Ribeiro RY; Meyer VS; De-Simone SG; Santos F; Moreno A; Barnwell JW; Galinski MR; Oliveira-Ferreira J
    Vaccine; 2011 Feb; 29(9):1801-11. PubMed ID: 21215342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
    Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
    Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of naturally acquired antibody responses against the C-terminal processing products of Plasmodium vivax Merozoite Surface Protein-1 under low transmission and unstable malaria conditions in Sri Lanka.
    Wickramarachchi T; Illeperuma RJ; Perera L; Bandara S; Holm I; Longacre S; Handunnetti SM; Udagama-Randeniya PV
    Int J Parasitol; 2007 Feb; 37(2):199-208. PubMed ID: 17055511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
    Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
    Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium vivax: dimorphic DNA sequences from the MSP-1 gene code for regions that are immunogenic in natural infections.
    Mancilla LI; Levitus G; Kirchgatter K; Mertens F; Herrera S; del Portillo HA
    Exp Parasitol; 1994 Sep; 79(2):148-58. PubMed ID: 8056078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
    Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
    Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
    Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
    Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium vivax: epitope mapping of monoclonal antibodies against the N-terminal region of the merozoite surface protein 1.
    Levitus G; Mertens F; Kirchgatter K; Oliveira SG; del Portillo HA
    Behring Inst Mitt; 1997 Mar; (99):107-11. PubMed ID: 9303209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians.
    Bastos MS; da Silva-Nunes M; Malafronte RS; Hoffmann EH; Wunderlich G; Moraes SL; Ferreira MU
    Clin Vaccine Immunol; 2007 Oct; 14(10):1249-59. PubMed ID: 17699838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
    Soares IS; Oliveira SG; Souza JM; Rodrigues MM
    Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.
    Tran TM; Oliveira-Ferreira J; Moreno A; Santos F; Yazdani SS; Chitnis CE; Altman JD; Meyer EV; Barnwell JW; Galinski MR
    Am J Trop Med Hyg; 2005 Aug; 73(2):244-55. PubMed ID: 16103583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.
    Fernandez-Becerra C; Sanz S; Brucet M; Stanisic DI; Alves FP; Camargo EP; Alonso PL; Mueller I; del Portillo HA
    Malar J; 2010 Jan; 9():29. PubMed ID: 20092651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-specific antibodies to Plasmodium vivax merozoite surface protein-1: prevalence and inverse relationship to haemoglobin levels during infection.
    Sepúlveda N; Morais CG; Mourão LC; Freire MF; Fontes CJ; Lacerda MV; Drakeley CJ; Braga ÉM
    Malar J; 2016 Nov; 15(1):559. PubMed ID: 27852258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.
    Bitencourt AR; Vicentin EC; Jimenez MC; Ricci R; Leite JA; Costa FT; Ferreira LC; Russell B; Nosten F; Rénia L; Galinski MR; Barnwell JW; Rodrigues MM; Soares IS
    PLoS One; 2013; 8(2):e56061. PubMed ID: 23457498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the naturally acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil.
    Storti-Melo LM; Souza-Neiras WC; Cassiano GC; Taveira LC; Cordeiro AJ; Couto VS; Póvoa MM; Cunha MG; Echeverry DM; Rossit AR; Arévalo-Herrera M; Herrera S; Machado RL
    Am J Trop Med Hyg; 2011 Feb; 84(2 Suppl):58-63. PubMed ID: 21292879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to the circumsporozoite protein of Plasmodium vivax in naturally infected humans.
    Franke ED; Lucas CM; Chauca G; Wirtz RA; Hinostroza S
    Am J Trop Med Hyg; 1992 Mar; 46(3):320-6. PubMed ID: 1373042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.